Slowly absorbable mesh versus standard care in the management of contaminated midline incisional hernia (COMpACT-BIO): a multicentre randomised controlled phase III trial including a health economic evaluation

Guillaume Passot, Jennifer Margier, Amaniel Kefleyesus, Pascal Rousset, Pablo Ortega-Deballon, Yohann Renard, Sylvie Bin, Laurent Villeneuve, Guillaume Passot, Jennifer Margier, Amaniel Kefleyesus, Pascal Rousset, Pablo Ortega-Deballon, Yohann Renard, Sylvie Bin, Laurent Villeneuve

Abstract

Introduction: Incisional hernia (IH) is the most frequent mid-term and long-term complication after midline laparotomy. The current standard treatment includes repair using a mesh. In a contaminated field, the use of a non-absorbable mesh increases the risk of surgical site infection and the costs. Slowly absorbable meshes are safe in contaminated fields, but no data have been reported regarding their long-term recurrence rate. COMpACT-BIO is a multicentre prospective randomised controlled phase III trial designed to compare the 3-year recurrence rate in patients undergoing contaminated IH repair with either a slowly absorbable mesh or standard care.

Methods: In patients undergoing midline IH repair in a contaminated surgical field (grade III of the modified Ventral Hernia Working Group classification), the COMpACT-BIO study compares the use of a slowly absorbable mesh with that of conventional care according to standardised surgical procedures (primary closure, non-absorbable synthetic mesh or biologic mesh, at the discretion of the surgeon). Randomisation is done during surgery before closure the fascia with an allocation ratio of 1:1. The choice of the slowly absorbable mesh is left to the criteria of each centre. The primary endpoint is the proportion of patients with scan-confirmed IH recurrence within 3 years after repair.

Ethics/dissemination: This trial is conducted in compliance with international standards for research practice and reporting. Written informed consent will be obtained from patients prior to inclusion. All data were identified and anonymised prior to analysis. The protocol has been approved by an Institutional Review Board (2020-A0823-36/SI:20.07.03.66831), and will be conducted in compliance with the CONSORT (Consolidated Standards of Reporting Trials) statement. Results will be submitted for publication in peer-reviewed medical journals and presented to patients and healthcare professionals.

Protocol version: Version 2-13 October 2020.

Trial registration number: NCT04597840.

Keywords: adult surgery; plastic & reconstructive surgery; wound management.

Conflict of interest statement

Competing interests: PO-D and GP received payments for counselling for Beckton & Dickinson and Medtronic within the past 5 years. YR received grants from BD(r), LifeCell/Acelity and Hartmann within the past 5 years.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Deerenberg EB, Harlaar JJ, Steyerberg EW, et al. . Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet 2015;386:1254–60. 10.1016/S0140-6736(15)60459-7
    1. Yahchouchy-Chouillard E, Aura T, Picone O, et al. . Incisional hernias. Dig Surg 2003;20:3–9. 10.1159/000068850
    1. Burger JWA, Luijendijk RW, Hop WCJ, et al. . Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 2004;240:578–85. 10.1097/01.sla.0000141193.08524.e7
    1. Holihan JL, Alawadi Z, Martindale RG, et al. . Adverse events after ventral hernia repair: the vicious cycle of complications. J Am Coll Surg 2015;221:478–85. 10.1016/j.jamcollsurg.2015.04.026
    1. Luijendijk RW, Hop WC, van den Tol MP, et al. . A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 2000;343:392–8. 10.1056/NEJM200008103430603
    1. Ventral Hernia Working Group, Breuing K, Butler CE, et al. . Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 2010;148:544–58. 10.1016/j.surg.2010.01.008
    1. van Ramshorst GH, Eker HH, Hop WCJ, et al. . Impact of incisional hernia on health-related quality of life and body image: a prospective cohort study. Am J Surg 2012;204:144–50. 10.1016/j.amjsurg.2012.01.012
    1. Xourafas D, Lipsitz SR, Negro P, et al. . Impact of mesh use on morbidity following ventral hernia repair with a simultaneous bowel resection. Arch Surg 2010;145:739–44. 10.1001/archsurg.2010.144
    1. Sahoo S, Haskins IN, Huang L-C, et al. . Early wound morbidity after open ventral hernia repair with biosynthetic or polypropylene mesh. J Am Coll Surg 2017;225:472–80. 10.1016/j.jamcollsurg.2017.07.1067
    1. Lin Y-T, Weng T-Y, Tam K-W. Effectiveness and safety of mesh repair for incarcerated or strangulated hernias: a systematic review and meta-analysis. World J Surg 2020;44:2176–84. 10.1007/s00268-020-05430-4
    1. Pandey H, Thakur DS, Somashekar U, et al. . Use of polypropylene mesh in contaminated and dirty strangulated hernias: short-term results. Hernia 2018;22:1045–50. 10.1007/s10029-018-1811-3
    1. Carbonell AM, Criss CN, Cobb WS, et al. . Outcomes of synthetic mesh in contaminated ventral hernia repairs. J Am Coll Surg 2013;217:991–8. 10.1016/j.jamcollsurg.2013.07.382
    1. Choi JJ, Palaniappa NC, Dallas KB, et al. . Use of mesh during ventral hernia repair in clean-contaminated and contaminated cases: outcomes of 33,832 cases. Ann Surg 2012;255:176–80. 10.1097/SLA.0b013e31822518e6
    1. Birolini C, de Miranda JS, Tanaka EY, et al. . The use of synthetic mesh in contaminated and infected abdominal wall repairs: challenging the dogma-A long-term prospective clinical trial. Hernia 2020;24:307–23. 10.1007/s10029-019-02035-2
    1. Maatouk M, Ben Safta Y, Mabrouk A, et al. . Surgical site infection in mesh repair for ventral hernia in contaminated field: a systematic review and meta-analysis. Ann Med Surg 2021;63:102173. 10.1016/j.amsu.2021.02.019
    1. Kanters AE, Krpata DM, Blatnik JA, et al. . Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs. J Am Coll Surg 2012;215:787–93. 10.1016/j.jamcollsurg.2012.08.012
    1. Primus FE, Harris HW. A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions. Hernia 2013;17:21–30. 10.1007/s10029-012-1037-8
    1. Rosen MJ, Krpata DM, Ermlich B, et al. . A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh. Ann Surg 2013;257:991–6. 10.1097/SLA.0b013e3182849871
    1. Sbitany H, Kwon E, Chern H, et al. . Outcomes analysis of biologic mesh use for abdominal wall reconstruction in clean-contaminated and contaminated ventral hernia repair. Ann Plast Surg 2015;75:201–4. 10.1097/SAP.0000000000000030
    1. Buell JF, Sigmon D, Ducoin C, et al. . Initial experience with biologic polymer scaffold (Poly-4-hydroxybuturate) in complex abdominal wall reconstruction. Ann Surg 2017;266:185–8. 10.1097/SLA.0000000000001916
    1. Plymale MA, Davenport DL, Dugan A, et al. . Ventral hernia repair with poly-4-hydroxybutyrate mesh. Surg Endosc 2018;32:1689–94. 10.1007/s00464-017-5848-7
    1. Roth JS, Anthone GJ, Selzer DJ, et al. . Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up. Surg Endosc 2018;32:1929–36. 10.1007/s00464-017-5886-1
    1. Madani A, Watanabe Y, Vassiliou M, et al. . Defining competencies for safe thyroidectomy: an international Delphi consensus. Surgery 2016;159:86-94, 96-10110.1016/j.surg.2015.07.039
    1. Heniford BT, Lincourt AE, Walters AL, et al. . Carolinas comfort scale as a measure of hernia repair quality of life: a reappraisal utilizing 3788 international patients. Ann Surg 2018;267:171–6. 10.1097/SLA.0000000000002027
    1. Parker SG, Halligan S, Liang MK, et al. . Definitions for loss of domain: an international Delphi consensus of expert surgeons. World J Surg 2020;44:1070–8. 10.1007/s00268-019-05317-z
    1. Renard Y, de Mestier L, Henriques J, et al. . Absorbable polyglactin vs. non-cross-linked porcine biological mesh for the surgical treatment of infected incisional hernia. J Gastrointest Surg 2020;24:435–43. 10.1007/s11605-018-04095-8
    1. Rosen MJ, Bauer JJ, Harmaty M, et al. . Multicenter, prospective, longitudinal study of the recurrence, surgical site infection, and quality of life after contaminated ventral hernia repair using biosynthetic absorbable mesh: the cobra study. Ann Surg 2017;265:205–11. 10.1097/SLA.0000000000001601
    1. Fleiss JL, Tytun A, Ury HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980;36:343–6. 10.2307/2529990

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe